Profile picture

Doctor Wern Yew Ding

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
Follow
Logo ESC

Contributor content

Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry
Presentation
Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry
Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry
Presentation
Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry
Clinical application of the novel 4S-AF scheme for the characterisation of patients with atrial fibrillation: a report from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
Presentation
Clinical application of the novel 4S-AF scheme for the characterisation of patients with atrial fibrillation: a report from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
Digoxin vs. beta-blocker therapy in atrial fibrillation: analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
Presentation
Digoxin vs. beta-blocker therapy in atrial fibrillation: analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
Stroke risk based on classification of atrial fibrillation: real-world vs clinical trial
Presentation
Stroke risk based on classification of atrial fibrillation: real-world vs clinical trial
Ablation Index-guided 50W radiofrequency ablation for atrial fibrillation: lesion level analysis to ascertain determinants of safety
Presentation
Ablation Index-guided 50W radiofrequency ablation for atrial fibrillation: lesion level analysis to ascertain determinants of safety
Novel tool for predicting residual stroke risk in atrial fibrillation: mCARS
Presentation
Novel tool for predicting residual stroke risk in atrial fibrillation: mCARS
Number needed to treat for net effect of anticoagulation in atrial fibrillation
Presentation
Number needed to treat for net effect of anticoagulation in atrial fibrillation